| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 12.04 | -9.26 | 10.86 | 2.48 |
Op profit growth | 27.37 | -8.99 | 56.86 | -12.39 |
EBIT growth | 22.11 | -3.58 | 40.34 | -19.19 |
Net profit growth | 373.19 | 284.25 | -72.32 | -10.45 |
Profitability ratios (%) | ||||
OPM | 23.24 | 20.44 | 20.38 | 14.4 |
EBIT margin | 23.47 | 21.53 | 20.26 | 16.01 |
Net profit margin | 51.69 | 12.24 | 2.89 | 11.58 |
RoCE | 36.37 | 37.43 | 33.85 | 22.08 |
RoNW | 20.46 | 5.42 | 1.21 | 4.01 |
RoA | 20.03 | 5.31 | 1.2 | 3.99 |
Per share ratios (₹) | ||||
EPS | 100.04 | 21.14 | 5.5 | 39.76 |
Dividend per share | 90 | 30 | 40 | 30 |
Cash EPS | 96.01 | 16.5 | 0.62 | 36.65 |
Book value per share | 157.19 | 87.26 | 107.47 | 236.92 |
Valuation ratios | ||||
P/E | 16.62 | 68.13 | 226.4 | 34.39 |
P/CEPS | 17.31 | 87.28 | 2,003.94 | 37.31 |
P/B | 10.57 | 16.5 | 11.58 | 5.77 |
EV/EBIDTA | 30.68 | 32.84 | 27.18 | 45.25 |
Payout (%) | ||||
Dividend payout | 0 | 0 | 0 | 75.44 |
Tax payout | -51.89 | -26.6 | -32.83 | -37.46 |
Liquidity ratios | ||||
Debtor days | 23.42 | 19.67 | 15.31 | 18.65 |
Inventory days | 60.2 | 64.23 | 51.43 | 59.71 |
Creditor days | -76.1 | -66.6 | -64.23 | -67.64 |
Leverage ratios | ||||
Interest coverage | -385.48 | -178.43 | -103.16 | -1,862.82 |
Net debt / equity | -0.92 | -0.75 | -0.59 | -0.44 |
Net debt / op. profit | -3.23 | -1.87 | -1.64 | -2.14 |
Cost breakup (₹) | ||||
Material costs | -41.37 | -42.96 | -40.56 | -48.05 |
Employee costs | -18.61 | -21.06 | -19.49 | -16.6 |
Other costs | -16.77 | -15.53 | -19.56 | -20.92 |
At around 2.14 PM, GSK Pharma was trading 0.28% higher at ₹2,806.70 per piece, against the previous close of ₹2,798.80 on NSE.
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
